BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22907195)

  • 1. Long-term hearing results and otological complications of nasopharyngeal carcinoma patients: comparison between treatment with conventional two-dimensional radiotherapy and intensity-modulated radiotherapy.
    Tsang RK; Kwong DL; Ho AC; To VS; Ho WK; Wei WI
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(4):228-33. PubMed ID: 22907195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.
    Hwang CF; Fang FM; Zhuo MY; Yang CH; Yang LN; Hsieh HS
    Biomed Res Int; 2015; 2015():769806. PubMed ID: 26351638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma.
    Li JJ; Guo YK; Tang QL; Li SS; Zhang XL; Wu PA; Yang XM
    J Laryngol Otol; 2010 Jan; 124(1):32-6. PubMed ID: 19840426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
    Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of postirradiated sudden deafness in nasopharyngeal carcinoma survivors during the past two decades.
    Cho TY; Cheng PW; Young YH
    Laryngoscope; 2016 Sep; 126(9):2016-21. PubMed ID: 26864918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical trials.
    Deng JY; Wang C; Shi XH; Jiang GL; Wang Y; Liu Y; Zhao KL
    Dis Esophagus; 2016 Nov; 29(8):1121-1127. PubMed ID: 26663710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of temporomandibular joint injuries after three-dimensional conformal and intensity-modulated radiotherapies for nasopharyngeal carcinoma].
    Chen D; Yu Y; Qi B; Liu J; Li M; Liang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):991-4. PubMed ID: 22820584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy.
    Wang LF; Kuo WR; Ho KY; Lee KW; Lin CS
    Otol Neurotol; 2004 Mar; 25(2):168-73. PubMed ID: 15021778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer?
    Ant A; Yazici Ö; Atabey P; Aslan FF; Duran A; Ozlugedik S; Kemaloglu YK
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):977-984. PubMed ID: 30671602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy.
    Zhou GQ; Yu XL; Chen M; Guo R; Lei Y; Sun Y; Mao YP; Liu LZ; Li L; Lin AH; Ma J
    PLoS One; 2013; 8(7):e67488. PubMed ID: 23874422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients.
    Hsin CH; Chen TH; Young YH; Liu WS
    Otolaryngol Head Neck Surg; 2010 Nov; 143(5):662-8. PubMed ID: 20974336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study.
    Ho WK; Wei WI; Kwong DL; Sham JS; Tai PT; Yuen AP; Au DK
    Head Neck; 1999 Sep; 21(6):547-53. PubMed ID: 10449671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
    Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
    Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of radiotherapy on retro-cochlear auditory pathways.
    Low WK; Burgess R; Fong KW; Wang DY
    Laryngoscope; 2005 Oct; 115(10):1823-6. PubMed ID: 16222203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
    Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
    Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
    Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
    Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.
    Qiu WZ; Peng XS; Xia HQ; Huang PY; Guo X; Cao KJ
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1563-1572. PubMed ID: 28342002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone use during radiotherapy extenuates hearing loss in patients with nasopharyngeal carcinoma.
    Chen J; Zhao Y; Zhou X; Tan L; Ou Z; Yu Y; Wang Y
    Laryngoscope; 2016 Jan; 126(1):100-3. PubMed ID: 26309227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.